Though there have been no large-scale clinical trials of the drug's
efficacy in treating coronavirus, chemists all over say they are
facing a shortage of the medicine, not so long ago known mainly to
those who had malaria or were prescribed it for arthritis pain. While
the demand for hydrochloroqine has seen a rapid uptick, the safety and
effectiveness of the drug in treating COVID-19 still remains a
concern.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/demand-surge-for-game-changer-covid-19-drug-hydroxychloroquine-despite-lack-of-clinical-evidence/articleshow/74967182.cms
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment